Carlsmed announced the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement.
Mike Cordonnier, CEO of Carlsmed, said, “We would like to recognize Dr. Christopher Ames at University of California San Francisco, Dr. Vijay Yanamadala at Hartford Healthcare, and Dr. Justin Smith at the University of Virginia Medical Center. These talented surgeons and their dedicated staff collaborated with Carlsmed and patients to complete the first in world aprevo® anterior, lateral, and transforaminal procedures respectively earlier this year as part of a Limited Clinical Release.”
Starting today, spine fusion procedures utilizing Carlsmed’s aprevo devices are eligible for additional reimbursement from CMS and private payors through the NTAP program.
Carlsmed announced the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement.
Mike Cordonnier, CEO of Carlsmed, said, “We would like to recognize Dr. Christopher Ames at University of California San Francisco, Dr. Vijay Yanamadala at Hartford Healthcare, and Dr. Justin Smith at...
Carlsmed announced the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement.
Mike Cordonnier, CEO of Carlsmed, said, “We would like to recognize Dr. Christopher Ames at University of California San Francisco, Dr. Vijay Yanamadala at Hartford Healthcare, and Dr. Justin Smith at the University of Virginia Medical Center. These talented surgeons and their dedicated staff collaborated with Carlsmed and patients to complete the first in world aprevo® anterior, lateral, and transforaminal procedures respectively earlier this year as part of a Limited Clinical Release.”
Starting today, spine fusion procedures utilizing Carlsmed’s aprevo devices are eligible for additional reimbursement from CMS and private payors through the NTAP program.
Copy to clipboard 
